Four-phase computed tomography helps differentiation of renal oncocytoma with central hypodense areas from clear cell renal cell carcinoma
Diagnostic and Interventional Radiology · 2023
DOI: 10.5152/dir.2022.21834 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diagnostic and Interventional Radiology, 2023. Verfasst von Jian-Yi Qu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Yantai Yuhuangding Hospital, Qingdao University School of Medicine, Yantai, China. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Adenoma, Oxyphilic, Kidney Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology, Yantai Yuhuangding Hospital, Qingdao University School of Medicine, Yantai, China
- Department of Pathology, Yantai Yuhuangding Hospital, Qingdao University School of Medicine, Yantai, China
ORCID-Profile: Jian-Yi Qu, Hong Jiang, Xin-Hong Song, Jin-Kun Wu, Heng Ma
Zitieren
APA
Qu, J. Y., Jiang, H., Song, X. H., Wu, J. K., & Ma, H. (2023). Four-phase computed tomography helps differentiation of renal oncocytoma with central hypodense areas from clear cell renal cell carcinoma. Diagnostic and Interventional Radiology. https://doi.org/10.5152/dir.2022.21834
Vancouver
Qu JY, Jiang H, Song XH, Wu JK, Ma H. Four-phase computed tomography helps differentiation of renal oncocytoma with central hypodense areas from clear cell renal cell carcinoma. Diagnostic and Interventional Radiology. 2023. doi:10.5152/dir.2022.21834
BibTeX
@article{Qu2023,
author = {Qu, Jian-Yi and Jiang, Hong and Song, Xin-Hong and Wu, Jin-Kun and Ma, Heng},
title = {Four-phase computed tomography helps differentiation of renal oncocytoma with central hypodense areas from clear cell renal cell carcinoma},
journal = {Diagnostic and Interventional Radiology},
year = {2023},
doi = {10.5152/dir.2022.21834}
}
EUVIMED